Active, not recruitingPhase 2NCT04209660
Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers
Studying Adenoid cystic carcinoma of the cervix uteri
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Principal Investigator
- Alan Ho, MD, PhDMemorial Sloan Kettering Cancer Center
- Intervention
- Lenvatinib(drug)
- Enrollment
- 64 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2020 – 2026
Study locations (8)
- Baptist Alliance MCI, Miami, Florida, United States
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (All protocol activities), Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack (All Protocol Activities), Commack, New York, United States
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale, New York, United States
Collaborators
Merck Sharp & Dohme LLC · Eisai Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04209660 on ClinicalTrials.govOther trials for Adenoid cystic carcinoma of the cervix uteri
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07507578A Multi-omics Approach to Disclose Progression and Underlying Biology of Head and Neck Adenoid Cystic CarcinomaFondazione IRCCS Istituto Nazionale dei Tumori, Milano
- RECRUITINGPHASE2NCT06781567Clinical Trial of HG146 Administered to Participants with Adenoid Cystic CarcinomaHitGen Inc.
- RECRUITINGPHASE2NCT04214366Adenoid Cystic Carcinoma and Carbon Ion Only IrradiationHeidelberg University
- RECRUITINGPHASE1, PHASE2NCT03556228VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaVM Oncology, LLC
See all trials for Adenoid cystic carcinoma of the cervix uteri →